Managing hematological malignancies in the COVID-19 era: 12 months on, what have we learned?
9 February 2021 —

Managing hematological malignancies in the COVID-19 era: 12 months on, what have we learned?

Join our expert faculty for this series of live, interactive broadcasts, each focussed on a specific topic relevant to hematologists treating patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin’s lymphoma (NHL).

Pre-register for your chance to submit questions to our expert faculty in advance of each broadcast. During each live broadcast you will also be able ...

more info...

Faculty

John Gribben

John Gribben

Paolo Ghia

Paolo Ghia

Christian Buske

Christian Buske
Sign up for this webinar
EM-49343
What's new in the ESMO guidelines?
11 February 2021 —

What's new in the ESMO guidelines?

Learning objective:

After participating in this broadcast you should be able to:

  • Explain the latest updates to the ESMO guidelines for managing patients with multiple myeloma  

 

Moderator:

  • Mohamad Mohty (France)

 

Faculty:

  • Philippe Moreau (France)
more info...

Faculty

Mohamad Mohty

Mohamad Mohty

Philippe Moreau

Philippe Moreau
Sign up for this webinar
EM-48507
Challenging cases in mantle cell lymphoma
23 February 2021 —

Challenging cases in mantle cell lymphoma

Join our expert faculty for this series of live, interactive broadcasts, each focussed on a specific topic relevant to hematologists treating patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin’s lymphoma (NHL).

Pre-register for your chance to submit questions to our expert faculty in advance of each broadcast. During each live broadcast you will also be able ...

more info...

Faculty

Georg Hess

Georg Hess

Steven Le Gouill

Steven Le Gouill

Ana Marín Niebla

Ana Marín Niebla
Sign up for this webinar
EM-49344
The key things you need to know about managing cardiac morbidities in patients with CLL
9 March 2021 —

The key things you need to know about managing cardiac morbidities in patients with CLL

Join our expert faculty for this series of live, interactive broadcasts, each focussed on a specific topic relevant to hematologists treating patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin’s lymphoma (NHL).

Pre-register for your chance to submit questions to our expert faculty in advance of each broadcast. During each live broadcast you will also be able ...

more info...

Faculty

John Gribben

John Gribben
Sign up for this webinar
EM-49345
High risk myeloma - what does it mean and how to treat it?
11 March 2021 —

High risk myeloma - what does it mean and how to treat it?

Learning objective:

After participating in this broadcast you should be able to:

  • Explain the definition of high-risk multiple myeloma and treatment options for patients  

 

Moderator:

  • Mohamad Mohty (France)

 

Faculty:

  • María Victoria Mateos (Spain)
more info...

Faculty

Mohamad Mohty

Mohamad Mohty

María Victoria Mateos

María Victoria Mateos
Sign up for this webinar
EM-48508
Challenging cases in Waldenström’s macroglobulinemia
23 March 2021 —

Challenging cases in Waldenström’s macroglobulinemia

Join our expert faculty for this series of live, interactive broadcasts, each focussed on a specific topic relevant to hematologists treating patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin’s lymphoma (NHL).

Pre-register for your chance to submit questions to our expert faculty in advance of each broadcast. During each live broadcast you will also be able ...

more info...

Faculty

Christian Buske

Christian Buske

Ramon Garcia-Sanz

Ramon Garcia-Sanz
Sign up for this webinar
EM-49346
Minimal Residual Disease - the end of the rainbow?
8 April 2021 —

Minimal Residual Disease - the end of the rainbow?

Learning objective:

After participating in this broadcast you should be able to:

  • Explain the role of minimal residual disease in the management of patients with multiple myeloma    

 

Moderator:

  • Mohamad Mohty (France)

 

Faculty:

  • Michel Delforge (Belgium)
  • Jesús San Miguel (Spain)
more info...

Faculty

Mohamad Mohty

Mohamad Mohty

Jesús San Miguel

Jesús San Miguel

Michel Delforge

Michel Delforge
Sign up for this webinar
EM-48509
Using genomics to guide clinical management in CLL
13 April 2021 —

Using genomics to guide clinical management in CLL

Join our expert faculty for this series of live, interactive broadcasts, each focussed on a specific topic relevant to hematologists treating patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin’s lymphoma (NHL).

Pre-register for your chance to submit questions to our expert faculty in advance of each broadcast. During each live broadcast you will also be able ...

more info...

Faculty

Gianluca Gaidano

Gianluca Gaidano

Kostas Stamatopoulos

Kostas Stamatopoulos
Sign up for this webinar
EM-49347
Where are we with MRD assessment in CLL management?
27 April 2021 —

Where are we with MRD assessment in CLL management?

Join our expert faculty for this series of live, interactive broadcasts, each focussed on a specific topic relevant to hematologists treating patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin’s lymphoma (NHL).

Pre-register for your chance to submit questions to our expert faculty in advance of each broadcast. During each live broadcast you will also be able ...

more info...

Faculty

Paolo Ghia

Paolo Ghia

Andrew Rawstron

Andrew Rawstron
Sign up for this webinar
EM-49349
AL Amyloidosis management in 2021: more progress than ever
4 May 2021 —

AL Amyloidosis management in 2021: more progress than ever

Learning objective:

After participating in this broadcast you should be able to:

  • Describe new developments in the management of patients with AL amyloidosis    

 

Moderator:

  • Michel Delforge (Belgium)

 

Faculty:

  • Giovanni Palladini (Italy)
more info...

Faculty

Michel Delforge

Michel Delforge

Giovanni Palladini

Giovanni Palladini
Sign up for this webinar
EM-48510